Correction
Accepted on 23 Feb 2026
RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression
in Cancer Molecular Targets and Therapeutics
Correction
Accepted on 23 Feb 2026
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 23 Feb 2026
in Genomics of Plants and Plant-Associated Organisms
Original Research
Accepted on 23 Feb 2026
in Cancer Cell Biology
Mini Review
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Feb 2026
in Health Economics
Original Research
Accepted on 23 Feb 2026
in Microbiotechnology
Original Research
Accepted on 23 Feb 2026
in Maternal Health
Original Research
Accepted on 23 Feb 2026
in Maternal Health
Review
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy
Correction
Accepted on 23 Feb 2026
in Environmental Informatics and Remote Sensing
Original Research
Accepted on 23 Feb 2026
in Life-Course Epidemiology and Social Inequalities in Health
Original Research
Accepted on 23 Feb 2026
in Addictive Disorders
Original Research
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Feb 2026
in Clinical Research in Auditory Implants and Hearing Aids
Case Report
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Feb 2026
in Public Health Policy